IP Library › Assignment 015148/0162
Patent Assignment
Reel/Frame 015148/0162

Change of Address for Cambridge Antibody Technology Limited

Recorded: 2004-09-17 Pages: 2
Assignor
Assignee
CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED
MILSTEIN BUILDING, GRANTA PARK, CAMBRIDGE, CB1 6GH, UNITED KINGDOM
Covered Property (1)
Specific Binding Proteins Including Antibodies Which Bind to the Necrotic Centre of Tumours, and Uses Thereof
Patent: 6,827,925 →
Application: 09/720,493 →
Related Assignments (8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor Interest; Re-Record to Correct the Number of Microfilm Pages from 6 to 5 at Reel 12328 Frame 0103 Dec 4, 2001
From: WILLIAMS, ANDREW JAMES; TEMPEST, PHILIP RONALD; HOLTET, THOR LAS; JACKSON, HELEN
To: CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED
Reel/Frame 012629/0346 →
Invalid Recording, See Document at Reel 012629 Frame 0346. (Re-Record to Correct Microfilm Pages Fraom 6 to 5) Dec 4, 2001
From: WILLIAMS, ANDREW JAMES; TEMPEST, PHILIP RONALD; HOLTET, THOR LAS; JACKSON, HELEN
To: CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED
Reel/Frame 012328/0103 →
Assignment of Assignor's Interest Dec 4, 2001
From: WILLIAMS, ANDREW JAMES; TEMPEST, PHILIP RONALD; HOLTET, THOR LAS; JACKSON, HELEN
To: CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED
Reel/Frame 012510/0557 →
Invalid Recording, See Document Document at Reel 012629, Frame 0346. (Re-Recorded to Correct the Microfilm Pages from 6 to 5) Dec 4, 2001
From: WILLIAMS, ANDREW JAMES; TEMPEST, PHILIP RONALD; HOLTET, THOR LAS; JACKSON, HELEN
To: CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED
Reel/Frame 012618/0606 →
Assignment of Assignor's Interest Nov 3, 2004
From: CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED
To: PEREGRINE PHARMACEUTICALS, INC.
Reel/Frame 015337/0550 →
Security Agreement Dec 22, 2008
From: PEREGRINE PHARMACEUTICALS, INC.
To: MIDCAP FUNDING I, LLC
Reel/Frame 022012/0694 →
Assignment of Assignor's Interest Feb 23, 2010
From: MIDCAP FUNDING I, LLC
To: MIDCAP FUNDING III, LLC
Reel/Frame 023973/0386 →
Release of Security Interest Dec 8, 2011
From: MIDCAP FUNDING III, LLC
To: PEREGRINE PHARMACEUTICALS, INC.
Reel/Frame 027347/0737 →